SANUWAVE Health, Inc. (SNWV) stock
Close on Nov 17, 2026Market cap $14.62MP/E –Yield –
Earnings
SANUWAVE Health's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of SANUWAVE Health's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Source |
|---|---|---|---|---|---|
| Q4 FY2026ended Dec 31, 2026 | Mar 25, 2027Expected | – | – | – | – |
| Q3 FY2026ended Sep 30, 2026 | Nov 10, 2026after the close | $8.60M | -25.2% | -$0.16 | Release |
| Q2 FY2026ended Jun 30, 2026 | Aug 6, 2026after the close | $9.70M | -4.9% | -$0.08 | Release |
| Q1 FY2026ended Mar 31, 2026 | May 12, 2026after the close | $9.60M | +2.8% | -$0.17 | Release |
| Q4 FY2025ended Dec 31, 2025 | Mar 26, 2026after the close | $13.40M | +30.1% | – | Release |
| Q3 FY2025ended Sep 30, 2025 | Nov 7, 2025before the open | $11.50M | +22.3% | $0.46 | Release |
| Q2 FY2025ended Jun 30, 2025 | Aug 8, 2025before the open | $10.20M | +41.7% | $0.01 | Release |
| Q1 FY2025ended Mar 31, 2025 | May 9, 2025before the open | $9.34M | +61.0% | -$0.66 | Release |
| Q4 FY2024ended Dec 31, 2024 | Mar 21, 2025before the open | $10.30M | +47.1% | – | Release |
| Q3 FY2024ended Sep 30, 2024 | Nov 8, 2024before the open | $9.40M | +88.0% | – | Release |
| Q2 FY2024ended Jun 30, 2024 | Aug 13, 2024before the open | $7.20M | +53.2% | – | Release |
| Q1 FY2024ended Mar 31, 2024 | May 10, 2024before the open | $5.80M | +52.6% | – | Release |
| Q4 FY2023ended Dec 31, 2023 | Mar 22, 2024before the open | $7.00M | +27.3% | – | Release |
| Q3 FY2023ended Sep 30, 2023 | Nov 13, 2023after the close | $5.00M | +19.0% | -$0.03 | Release |
| Q2 FY2023ended Jun 30, 2023 | Aug 11, 2023after the close | $4.70M | – | -$0.01 | Release |
| Q1 FY2023ended Mar 31, 2023 | May 12, 2023before the open | $3.80M | – | -$0.02 | Release |
| Q4 FY2022ended Dec 31, 2022 | Apr 3, 2023after the close | $5.50M | – | – | Release |
| Q3 FY2022ended Sep 30, 2022 | Nov 15, 2022after the close | $4.20M | – | $0.00 | Release |
| Q1 FY2020ended Mar 31, 2020 | May 18, 2020during market hours | – | – | – | Filing |
| Q3 FY2019ended Sep 30, 2019 | Nov 18, 2019during market hours | – | – | – | Filing |
| Q2 FY2019ended Jun 30, 2019 | Aug 19, 2019during market hours | – | – | – | Filing |
| Q1 FY2019ended Mar 31, 2019 | Apr 3, 2019during market hours | – | – | – | Filing |
| Q3 FY2018ended Sep 30, 2018 | Nov 20, 2018during market hours | – | – | – | Filing |
| Q2 FY2018ended Jun 30, 2018 | Aug 15, 2018after the close | – | – | – | Filing |
| Q1 FY2018ended Mar 31, 2018 | May 18, 2018during market hours | – | – | – | Filing |
| Q3 FY2017ended Sep 30, 2017 | Nov 22, 2017after the close | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
SANUWAVE Health's latest outlook for periods it has not reported yet, compared with what it said before
| Metric | Period | Guidance | Before | Change | Given |
|---|---|---|---|---|---|
| revenue | FY2026 | $51.00M – $55.00M | – | New | Mar 26, 2026 |
| revenue guidance | FY2026 | $51.00M – $55.00M | – | New | May 12, 2026 |
Guidance vs results
The last range SANUWAVE Health gave before each report, against the figure it then reported. Full years add up the four quarters.
| Period | Metric | Guidance | Actual | Result |
|---|---|---|---|---|
| Q2 FY2026 | Revenue | $11.10M – $11.60M | $9.70M | Below range |
| Q1 FY2026 | Revenue | $9.60M – $10.30M | $9.60M | Within range |
| FY2025 | Revenue | $44.00M – $45.00M | $44.44MΣ4Q | Within range |
| FY2025 | Revenue growth | +35% – +39% | +35.9%Σ4Q | Within range |
| Q4 FY2025 | Revenue | $13.00M – $14.00M | $13.40M | Within range |
| Q3 FY2025 | Revenue | $12.00M – $12.70M | $11.50M | Below range |
| Q2 FY2025 | Revenue | $10.00M – $10.70M | $10.20M | Within range |
| Q1 FY2025 | Revenue | $8.40M – $9.00M | $9.34M | Above range |
| Q4 FY2024 | Revenue | $9.70M – $10.50M | $10.30M | Within range |
| Q4 FY2024 | Revenue growth | +40% – +50% | +47.14% | Within range |
| Q3 FY2024 | Revenue | $8.00M – $8.50M | $9.40M | Above range |
| Q3 FY2024 | Revenue growth | +65% – +75% | +88% | Above range |
| Q2 FY2024 | Revenue growth | +45% – +55% | +53.19% | Within range |
| Q1 FY2024 | Revenue growth | +45% – +55% | +52.63% | Within range |
| Q4 FY2023 | Revenue growth | +15% – +25% | +27.27% | Above range |
| Q3 FY2023 | Revenue growth | +15% – +25% | +19.05% | Within range |
Guidance history
Every forecast SANUWAVE Health put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| May 12, 2026 | revenue | Q2 FY2026 | $11.10M – $11.60M | New |
| May 12, 2026 | revenue guidance | FY2026 | $51.00M – $55.00M | New |
| Mar 26, 2026 | revenue | FY2026 | $51.00M – $55.00M | New |
| Mar 26, 2026 | revenue | Q1 FY2026 | $9.60M – $10.30M | New |
| Nov 7, 2025 | revenue | FY2025 | +35% – +39% | New |
| Nov 7, 2025 | full year revenue | FY2025 | $44.00M – $45.00M | New |
| Nov 7, 2025 | revenue | Q4 FY2025 | $13.00M – $14.00M | New |
| Aug 8, 2025 | revenue | Q3 FY2025 | $12.00M – $12.70M | New |
| Aug 8, 2025 | revenue guidance | FY2025 | $48.00M – $50.00M | Reaffirmed |
| May 9, 2025 | revenue | Q2 FY2025 | $10.00M – $10.70M | New |
| May 9, 2025 | revenue guidance | FY2025 | $48.00M – $50.00M | Reaffirmed |
| Mar 21, 2025 | revenue | Q1 FY2025 | $8.40M – $9.00M | New |
| Mar 21, 2025 | revenue guidance | FY2025 | $48.00M – $50.00M | New |
| Nov 8, 2024 | revenue growth | Q4 FY2024 | +40% – +50% | New |
| Nov 8, 2024 | revenue | Q4 FY2024 | $9.70M – $10.50M | New |
| Nov 8, 2024 | revenues increase | FY2024 | +57% | Raised |
| Nov 8, 2024 | revenues | FY2024 | $32.00M | New |
| Aug 13, 2024 | revenue growth | Q3 FY2024 | +65% – +75% | New |
| Aug 13, 2024 | revenue | Q3 FY2024 | $8.00M – $8.50M | New |
| May 10, 2024 | revenue | Q2 FY2024 | +45% – +55% | New |
| May 10, 2024 | revenue growth guidance | FY2024 | +50% | Reaffirmed |
| Mar 22, 2024 | revenue growth | Q1 FY2024 | +45% – +55% | New |
| Mar 22, 2024 | revenue growth | FY2024 | +50% | New |
| Nov 13, 2023 | revenue | Q4 FY2023 | +15% – +25% | New |
| Aug 11, 2023 | revenue growth | Q3 FY2023 | +15% – +25% | New |
| May 12, 2023 | revenue growth | Q2 FY2023 | +15% – +25% | New |
| Apr 3, 2023 | revenue growth | Q1 FY2023 | +14% – +20% | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases SANUWAVE Health filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Results
- Update
- Results
- Results
- Results
- Results
- Update
- Results
- Results
- Update
- Results
- Results
- Results
See a number that looks wrong?